Trials that use: Fisher exact test
New to this method? Read the tutorial →
4,441 results
- An App to Reduce Cannabis Use Among Emerging Adults: Complete Statistical AnalysisIndependent statistical analysis of An App to Reduce Cannabis Use Among Emerging Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05824754).
- An Automated Virtual Reality Intervention to Enhance Firearm Safety Counseling in Pediatrics: Complete Statistical AnalysisIndependent statistical analysis of An Automated Virtual Reality Intervention to Enhance Firearm Safety Counseling in Pediatrics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy: Complete Statistical AnalysisIndependent statistical analysis of An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy: primary endpoint results, effect estimate with confidence interval, sample-size…
- An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma: primary endpoint results, effect estimate with…
- An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections: primary endpoint results, effect estimate with confidence interval,…
- An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Ivacaftor in Patients With Cystic Fibrosis and Two Splicing Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab Versus Nivolumab Monotherapy in Participants With Advanced Adenocarcinoma of the Lung:…
- An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging: primary endpoint results, effect estimate with confidence…
- An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics: primary endpoint results, effect estimate with confidence interval,…
- An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients: primary endpoint results, effect estimate with confidence interval, sample-size…
- An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne: Complete Statistical AnalysisIndependent statistical analysis of An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions: Complete Statistical AnalysisIndependent statistical analysis of An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients: Complete Statistical AnalysisIndependent statistical analysis of An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge: Complete Statistical AnalysisIndependent statistical analysis of An Evaluation of Repeated Oral Doses of JNJ-64281802 Against DENV-3 Challenge: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- An Evaluation of the Safety and Performance of the CathVision ECGenius® System.: Complete Statistical AnalysisIndependent statistical analysis of An Evaluation of the Safety and Performance of the CathVision ECGenius® System.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.: Complete Statistical AnalysisIndependent statistical analysis of An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD: Complete Statistical AnalysisIndependent statistical analysis of An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD: primary endpoint results, effect estimate with confidence interval, sample-size…
- An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection: Complete Statistical AnalysisIndependent statistical analysis of An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study: Complete Statistical AnalysisIndependent statistical analysis of An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus: Complete Statistical AnalysisIndependent statistical analysis of An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease: Complete Statistical AnalysisIndependent statistical analysis of An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia: Complete Statistical AnalysisIndependent statistical analysis of An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size…
- An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease: primary endpoint results, effect estimate…
- An Innovative Conversational Agent (Quitbot) for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of An Innovative Conversational Agent (Quitbot) for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04308759).
- An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR: Complete Statistical AnalysisIndependent statistical analysis of An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys: Complete Statistical AnalysisIndependent statistical analysis of An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of An Observational Study of Bevacizumab in Combination With 5-FU-Based Chemotherapy in Chinese Participants With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine: Complete Statistical AnalysisIndependent statistical analysis of An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma: Complete Statistical AnalysisIndependent statistical analysis of An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma: primary endpoint results, effect…
- An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant: Complete Statistical AnalysisIndependent statistical analysis of An Observational Study of Methoxy Polyethylene Glycol-epoetin Beta in Participants With a Kidney Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- An Observational Study on the Natural Course of Chronic Pancreatitis: Complete Statistical AnalysisIndependent statistical analysis of An Observational Study on the Natural Course of Chronic Pancreatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04574297).
- An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored…
- An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Open Label Study for Participants With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Study for Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01215942).
- An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- An Open Label Trial of Bupropion and Naltrexone for Binge Drinking: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Trial of Bupropion and Naltrexone for Binge Drinking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects: Complete Statistical AnalysisIndependent statistical analysis of An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects: primary endpoint results, effect estimate with confidence…
- An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD): Complete Statistical AnalysisIndependent statistical analysis of An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD): primary endpoint results, effect estimate with…
- An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor: primary endpoint results,…
- An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area: Complete Statistical AnalysisIndependent statistical analysis of An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…